boric acid has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brotman, RM; Ghanem, KG; Powell, A; Rogers, L; Tuddenham, S; Zenilman, J; Zinalabedini, A | 1 |
| Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S | 1 |
| Wilson, C | 1 |
| Ringdahl, EN | 1 |
| Alberico, S; De Santo, D; De Seta, F; Guaschino, S; Piccoli, M; Ricci, G; Sartore, A | 1 |
| Congema, E; Jovanovic, R; Nguyen, HT | 1 |
2 review(s) available for boric acid and Recrudescence
| Article | Year |
|---|---|
Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Causality; Complementary Therapies; Drug Prescriptions; Drug Resistance, Fungal; Female; Garlic; Humans; Lactobacillus acidophilus; Nonprescription Drugs; Prevalence; Recurrence; Self Care; Tea Tree Oil; Treatment Outcome; Yogurt | 2005 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
1 trial(s) available for boric acid and Recrudescence
| Article | Year |
|---|---|
Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Predictive Value of Tests; Recurrence; Vaginal Smears | 1991 |
3 other study(ies) available for boric acid and Recrudescence
| Article | Year |
|---|---|
Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Boric Acids; Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Humans; Middle Aged; Patient Satisfaction; Recurrence; Retrospective Studies; Treatment Outcome; Vaginosis, Bacterial | 2019 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cell Adhesion; Epithelial Cells; Female; Fluconazole; Fungal Proteins; Hemolysis; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Phospholipases; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Saccharomyces cerevisiae; Vagina; Virulence Factors; Young Adult | 2012 |
Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Boric Acids; Candidiasis; Female; Humans; Itraconazole; Prospective Studies; Recurrence; Vaginal Diseases; Vulvar Diseases | 2001 |